Iggy Njoku | Head, IR |
Oleg Movchan | CEO |
Brad Herring | CFO |
Kevin McVeigh | Credit Suisse |
Parker Lane | Stifel |
James Faucette | Morgan Stanley |
Callie Valenti | Goldman Sachs |
Dylan Becker | William Blair |
Good morning, ladies and gentlemen, and thank you for standing by. Welcome to Enfusion Second Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
I'd now like to turn the call over to Iggy Njoku, Head of Investor Relations, to begin.
Good morning, and thank you, operator.